SCHEMBL2239331

SCHEMBL2239331

C[SiH](CCCc1ccccc1)O[SiH3]

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
SIGMAR1 Q99720 5/20 0.42
MAOA P21397 1/20 0.42
CHRM2 P08172 1/20 0.41
HTR1A P08908 1/20 0.41
ADRA2A P08913 1/20 0.41
CHRM1 P11229 1/20 0.41
DRD1 P21728 1/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A4 P31645 1/20 0.41
ADRA1A P35348 1/20 0.41
OPRM1 P35372 1/20 0.41
DRD3 P35462 1/20 0.41
SLC6A3 Q01959 1/20 0.41
KCNH2 Q12809 1/20 0.41
AOC3 Q16853 1/20 0.41
MAOB P27338 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL338863 0.88 ALDH1A1 (0.41) IDO1L3MBTL1MAOAAOC3MAOB
SCHEMBL11653956 0.84 IDO1 (0.38) IDO1L3MBTL1MEN1KMT2ASIGMAR1
SCHEMBL19927446 0.83 IDO1 (0.45) IDO1L3MBTL1MEN1KMT2ASIGMAR1
SCHEMBL476048 0.79 L3MBTL1 (0.48) L3MBTL1MEN1KMT2ASIGMAR1MAOA
SCHEMBL2510929 0.77 TP53 (0.39) IDO1SIGMAR1SLC6A2
SCHEMBL16684742 0.77 MAOA (0.56) MEN1KMT2ASIGMAR1MAOACHRM2
SCHEMBL705764 0.73 IDO1 (0.45) IDO1L3MBTL1MEN1KMT2ASIGMAR1
SCHEMBL17386453 0.73 TDP1 (0.52) IDO1L3MBTL1SIGMAR1MAOAADRA1A
SCHEMBL3482262 0.73 IDO1 (0.46) IDO1SIGMAR1CHRM2HTR1AADRA2A
SCHEMBL2803699 0.72 MAOA (0.52) L3MBTL1MEN1KMT2ASIGMAR1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110190467-A1 Biological Polysiloxanes VISION CRC LIMITED (AU) 2011-08-04 US disclosed
US-20090276042-A1 Biological Polysiloxanes VISION CRC LIMITED (AU) 2009-11-05 US disclosed
EP-2021399-A1 BIOLOGICAL POLYSILOXANES VISION CRC LIMITED (AU) 2009-02-11 EP disclosed
WO-2007128051-A1 BIOLOGICAL POLYSILOXANES VISION CRC LIMITED (AU) 2007-11-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090276042-A1 Biological Polysiloxanes PBK, B2M, CD79B IDO1 4333/4885L3MBTL1 410/4885MEN1 782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.